Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

NCT04579588 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT04579588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04579588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
Lead sponsor
Stanford University
Phase
Observational
Overall status
Recruiting
Start date
October 29, 2020
Completion date
April 30, 2028
Enrollment
230 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, flu vaccine, immunity